Medication Labeling and Expiration Tracking Deficiency
Penalty
Summary
The facility failed to properly label and manage medications for four residents, leading to deficiencies in medication storage and expiration tracking. During an inspection, it was observed that medications for residents R315, R32, R4, and R33 were either not dated upon opening or not removed after their use-by date. Specifically, R315's and R32's Trelegy Ellipta inhalers were opened but not dated, which is crucial for determining their expiration as they should be discarded six weeks after opening. R4's Fluticasone propionate/Salmeterol inhaler was opened on January 20, 2025, but not discarded by its expiration date of February 20, 2025, and R4's Incruse Ellipta was also opened without a date. Similarly, R33's Arnuity Ellipta was opened and not dated. The Director of Nursing confirmed that staff are required to date all medications upon opening to ensure compliance with manufacturer's guidelines.